Trastuzumab Deruxtecan
Commons · Question 3642 · Tabled 30 Aug 2024 · Department of Health and Social Care · Official record
Answered 10 Sep 2024
Question
Asked by Joshua Reynolds
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of providing access to Enhertu on the NHS for cancer patients.
Answer
Answered by Karin Smyth, 10 Sep 2024
Decisions on whether new medicines should be routinely funded by the NHS in England are taken by the National Institute for Health and Care Excellence (NICE) on the basis of an evaluation of a treatment’s costs and benefits. NICE’s methods are internation...